A. Aydiner Et Al. , "The combination of gemcitabine and cisplatin as neoadjuvant chemotherapy for early stage non-small cell lung carcinoma (NSCLC): An interim analysis of a phase II trial.," 41st Annual Meeting of the American-Society-of-Clinical-Oncology , vol.23, Florida, United States Of America, 2005
Aydiner, A. Et Al. 2005. The combination of gemcitabine and cisplatin as neoadjuvant chemotherapy for early stage non-small cell lung carcinoma (NSCLC): An interim analysis of a phase II trial.. 41st Annual Meeting of the American-Society-of-Clinical-Oncology , (Florida, United States Of America).
Aydiner, A., Kiyik, M., Cikrikcioglu, S., Kosar, F., Gurses, A., Turna, A., ... Yazar, A.(2005). The combination of gemcitabine and cisplatin as neoadjuvant chemotherapy for early stage non-small cell lung carcinoma (NSCLC): An interim analysis of a phase II trial. . 41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America
Aydiner, Adnan Et Al. "The combination of gemcitabine and cisplatin as neoadjuvant chemotherapy for early stage non-small cell lung carcinoma (NSCLC): An interim analysis of a phase II trial.," 41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 2005
Aydiner, Adnan Et Al. "The combination of gemcitabine and cisplatin as neoadjuvant chemotherapy for early stage non-small cell lung carcinoma (NSCLC): An interim analysis of a phase II trial.." 41st Annual Meeting of the American-Society-of-Clinical-Oncology , Florida, United States Of America, 2005
Aydiner, A. Et Al. (2005) . "The combination of gemcitabine and cisplatin as neoadjuvant chemotherapy for early stage non-small cell lung carcinoma (NSCLC): An interim analysis of a phase II trial.." 41st Annual Meeting of the American-Society-of-Clinical-Oncology , Florida, United States Of America.
@conferencepaper{conferencepaper, author={Adnan AYDINER Et Al. }, title={The combination of gemcitabine and cisplatin as neoadjuvant chemotherapy for early stage non-small cell lung carcinoma (NSCLC): An interim analysis of a phase II trial.}, congress name={41st Annual Meeting of the American-Society-of-Clinical-Oncology}, city={Florida}, country={United States Of America}, year={2005}}